These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 16515591

  • 1. Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells.
    Beiner ME, Niv H, Haklai R, Elad-Sfadia G, Kloog Y, Ben-Baruch G.
    Int J Gynecol Cancer; 2006; 16 Suppl 1():200-6. PubMed ID: 16515591
    [Abstract] [Full Text] [Related]

  • 2. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
    Jiang C, Song T, Li J, Ao F, Gong X, Lu Y, Zhang C, Chen L, Liu Y, He H, Huang O.
    Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020
    [Abstract] [Full Text] [Related]

  • 5. Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc.
    Yaari-Stark S, Shaked M, Nevo-Caspi Y, Jacob-Hircsh J, Shamir R, Rechavi G, Kloog Y.
    Int J Cancer; 2010 May 15; 126(10):2268-81. PubMed ID: 19998334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 9. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 14; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
    Weisz B, Giehl K, Gana-Weisz M, Egozi Y, Ben-Baruch G, Marciano D, Gierschik P, Kloog Y.
    Oncogene; 1999 Apr 22; 18(16):2579-88. PubMed ID: 10353601
    [Abstract] [Full Text] [Related]

  • 12. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R.
    J Hepatol; 1999 Dec 22; 31(6):1053-61. PubMed ID: 10604579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R, Elkon R, Yaari S, Zundelevich A, Jacob-Hirsch J, Rechavi G, Shamir R, Kloog Y.
    Cancer Res; 2007 Apr 01; 67(7):3320-8. PubMed ID: 17409441
    [Abstract] [Full Text] [Related]

  • 15. Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells.
    Smalley KS, Eisen TG.
    Int J Cancer; 2003 Jun 10; 105(2):165-75. PubMed ID: 12673674
    [Abstract] [Full Text] [Related]

  • 16. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
    Stärkel P, Charette N, Borbath I, Schneider-Merck T, De Saeger C, Abarca J, Leclercq I, Horsmans Y.
    Mol Carcinog; 2012 Oct 10; 51(10):816-25. PubMed ID: 21882255
    [Abstract] [Full Text] [Related]

  • 17. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
    Haklai R, Elad-Sfadia G, Egozi Y, Kloog Y.
    Cancer Chemother Pharmacol; 2008 Jan 10; 61(1):89-96. PubMed ID: 17909812
    [Abstract] [Full Text] [Related]

  • 18. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
    Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y.
    Mol Cancer Ther; 2010 Aug 10; 9(8):2208-19. PubMed ID: 20682656
    [Abstract] [Full Text] [Related]

  • 19. Novel Ras antagonist blocks human melanoma growth.
    Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y, Wolff K.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14019-24. PubMed ID: 10570191
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J, Sack J, Barshack I, Keren P, Goldberg I, Haklai R, Elad-Sfadia G, Kloog Y, Keren G.
    Arterioscler Thromb Vasc Biol; 2004 Feb 23; 24(2):363-8. PubMed ID: 14670932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.